Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Tab visibility
Self-correcting amplifier system
Method and system for calibrating laser profiling systems
Hydrothermal synthesis of nanocubes of sillenite type compounds for photovoltaic applications and solar energy conversion of carbon dioxide to fuels
Novelty snacks and method of manufacture of same
Multi-dimensional credibility scoring
Measuring current and resistance using combined diodes/resistor structure to monitor integrated circuit manufacturing process variations
  Randomly Featured Patents
Power control circuits with enhanced nonlinear current sensing
Liquid applying apparatus and an image forming substance removing apparatus
Light emitting diode drive circuit
Air cleaning system unit
Speaker box
Wireless trusted point of access to a computer network
Seat belt buckle pretensioner with end cap
Cushioned tread tire
Eyeglass frame
Combination soil conditioning rotary reel and primary tillage system